EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid‐Assisted Model

Yi-Jing Zhao iD, Yong Li iD, Feng-Xiang Wang iD, Hao Lv iD, Yaoyao Qu iD, Lian-Wen Qi iD, Pingxi Xiao iD

Cardiovascular Therapeutics · 2024

DOI: 10.1155/2024/9935805 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiovascular Therapeutics, 2024. Verfasst von Yi-Jing Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines School of Traditional Chinese Pharmacy China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Coronary Artery Disease, Amino Acids, Myocardial Infarction, Predictive Value of Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with stable coronary artery disease (CAD) are at an increased risk of acute myocardial infarction (AMI), particularly among older individuals. Developing a reliable model to predict AMI occurrence in these patients holds the potential to expedite early diagnosis and intervention. This study is aimed at establishing a circulating amino acid‐assisted model, incorporating amino acid profiles alongside clinical variables, to predict AMI risk. A cohort of 874 CAD patients from two independent centers was analyzed. Plasma amino acid levels were quantified using liquid chromatography tandem mass spectrometry (LC‐MS/MS) employing a targeted metabolomics approach. This methodology incorporated 13 C isotope‐labeled internal standards for precise quantification of 27 amino acids. Univariate logistic regression was applied to identify differentially expressed amino acids that distinguished between stable CAD and AMI patients. To assess prediction performance, receiver operating characteristic (ROC) curve and nomogram analyses were utilized. Five amino acids—lysine, methionine, tryptophan, tyrosine, and N6‐trimethyllysine—emerged as potential biomarkers ( p < 0.05), exhibiting significant differences in their expression levels across the two centers when comparing stable CAD with AMI patients. For AMI risk prediction, the base model, utilizing 12 clinical variables, achieved areas under the curve (AUC) of 0.7387 in the discovery phase ( n = 623) and 0.8205 in the external validation set ( n = 251). Notably, the integration of these five amino acids into the prediction model significantly enhanced its performance, increasing the AUC to 0.7651 in the discovery phase (Delong’s test, p = 1.43e‐02) and to 0.8958 in the validation set (Delong’s test, p = 8.91e‐03). In conclusion, the circulating amino acid‐assisted model effectively enhances the prediction of AMI risk among CAD patients, indicating its potential clinical utility in facilitating early detection and intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseAmino AcidsMyocardial InfarctionPredictive Value of TestsBiomarkersHumansRisk AssessmentMaleFemaleAgedMiddle AgedRisk FactorsPrognosisNomogramsMetabolomicsTandem Mass SpectrometryDecision Support TechniquesReproducibility of ResultsChromatography, LiquidChina

Stichwörter der Autor:innen

acute myocardial infarctionamino acidcoronary artery diseasemethylated amino acidrisk prediction

Substanzen

Amino AcidsBiomarkers

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines School of Traditional Chinese Pharmacy China Pharmaceutical University, Nanjing, China.
  • Department of Cardiology Pukou Hospital of Chinese Medicine Affiliated to China Pharmaceutical University, Nanjing, China.
  • Department of Cardiology The Affiliated Wujin Hospital of Jiangsu University, Changzhou, China.
  • The Clinical Metabolomics Center China Pharmaceutical University, Nanjing, China.
  • Department of Cardiology The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Yi-Jing Zhao, Yong Li, Feng-Xiang Wang, Hao Lv, Yaoyao Qu, Lian-Wen Qi, Pingxi Xiao

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhao, Y. J., Li, Y., Wang, F. X., Lv, H., Qu, Y., Qi, L. W., & Xiao, P. (2024). Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid‐Assisted Model. Cardiovascular Therapeutics. https://doi.org/10.1155/2024/9935805

Vancouver

Zhao YJ, Li Y, Wang FX, Lv H, Qu Y, Qi LW, et al. Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid‐Assisted Model. Cardiovascular Therapeutics. 2024. doi:10.1155/2024/9935805

BibTeX
@article{Zhao2024,
  author = {Zhao, Yi-Jing and Li, Yong and Wang, Feng-Xiang and Lv, Hao and Qu, Yaoyao and Qi, Lian-Wen and Xiao, Pingxi},
  title = {Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid‐Assisted Model},
  journal = {Cardiovascular Therapeutics},
  year = {2024},
  doi = {10.1155/2024/9935805}
}
Kostenlos starten →